Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept Injection With Panretinal Photocoagulation Versus Early Vitrectomy for Diabetic Vitreous Hemorrhage

NCT04153253 is registered in ClinicalTrials.gov with Al Hadi Hospital as lead sponsor.

NCT NCT04153253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept Injection With Panretinal Photocoagulation Versus Early Vitrectomy for Diabetic Vitreous Hemorrhage
Lead sponsor
Al Hadi Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 7, 2018
Completion date
September 29, 2019
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic vitreous hemorrhage